Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP
In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding
Univ. Of Pittsburg distances Itself From Fisher
Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths
A Transcript: what Fisher Knew, When Did He Know
NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said
Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









